1. 川本　徹　
住院医师实习指导 – 腹部疾病 2 Vector Core Co., Ltd.
“胆囊炎、胆石症” 分享　２月　2006

2. 川本　徹、轟　健、深尾　立　图解消化疾病系列13《胆道疾病》医学观点出版　「6.胆道癌分期分类」　作业164 -171 2000

3. 川本　徹　临床医学最低纲领 金原出版社
消化系统疾病的治疗 分享 348 – 350 2000

４．Todoroki K, Kawamoto T, Otsuka M, Takada Y, Atachi S, Yuzawa K,
Koike N, Yoshida S, Fukao K, Ohara K
IORT combined with resection for Stage IV gallbladder carcinoma Vaeth JM(ed): Therapy in the Treatment of Cancer　Front Radiat Ther Oncol. Karger,, 3: 165 – 172 1997

5.《脂肪肝》Gentosha Media Consulting 2022年3月1日第1次印刷

6. “最后，90%是肠子” Ascom　2022年7月11日，第1次印刷

1.Suzuki H, Roa JC, Kawamoto T, Ishige K, Wistuba II, Li D, Thomas MB, Shoda J.
Expression of insulin-like growth factor I receptor as a biomarker for predicting prognosis in biliary tract cancer patients. Molecular and Clinical Oncology 3: 464-470 2015

2.Miyahara N, Shoda J, Kawamoto T, Ishida H, Ueda T, Akimoto Y, Kawakami H, Irimura T.
Interaction of Muc4 and ErbB2 in a transgenic mouse model of gallbladder carcinoma: potential pathobiological implications. Oncol Rep. 2014 32(5):1796-802

3.Kawamoto T, Ishige K, Thomas M,Yamashita-Kashima Y, Shu S, Ishikura N, Ariizumi S, Yamamoto M, Kurosaki K, Shoda J
Overexpression and Gene Amplification of EGFR, HER2, and HER3 in Biliary Tract Carcinomas, and the Possibility for Therapy with the HER2-Targeting Antibody Pertuzumab J Gastroenterol 2014 Aug 12

4. Matsuda A, Kuno A, Matsuzaki H, Kawamoto T, Shikanai T, Nakanuma Y, Yamamoto M, Ohkohchi N, Ikehara Y, Shoda J, Hirabayashi J, Narimatsu H.
Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma.
J Proteomics. 2013 85:1-11

5. Onuki K, Sugiyama H, Ishige K, Kawamoto T, Ota T, Ariizumi S, Yamato M, Kadota S, Takeuchi K, Ishikawa A, Onodera M, Onizawa K, Yamamoto M, Miyoshi E, Shoda J.
Expression of N-acetylglucosaminyltransferase V in the subserosal layer correlates with postsurgical survival of pathological tumor stage 2 carcinoma of the gallbladder.
J Gastroenterol. 2013 Apr 17.

6. Shoda J1, Ishige K, Sugiyama H, Kawamoto T.
Biliary tract carcinoma: clinical perspectives on molecular targeting strategies for therapeutic options.J Hepatobiliary Pancreat Sci. 2012 19:342-53.

7. Matsuda A, Kuno A, Kawamoto T, Matsuzaki H, Irimura T, Ikehara Y, Zen Y, Nakanuma Y, Yamamoto M, Ohkohchi N, Shoda J, Hirabayashi J, Narimatsu H Wisteria floribunda agglutinin-positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma. Hepatology 2010 52:174-182

8.Matsuda A, Kuno A, Ishida H, Kawamoto T, Shoda J, Hirabayashi J. Development of all-in-one technology for glycan profiling targeting formalin-embedded tissue sections. Biochem Biophys Res Commun. 2008 30;370(2):259-63

9. Ishige K, Shoda J , Kawamoto T, Matsuda S , Ueda T , Hyodo I , Ohkohchi N , Puri RK , Kawakami K Potent in vitro and in vivo antitumor activity of interleukin- 4 – conjugated Pseudomonas exotoxin against human biliary tract carcinoma. Int J Cancer. 2008 123: 2915-2922

10. Colby JKL, Klein RD, McArthur MJ, Conti CJ, Kiguchi K, Kawamoto T, Riggs PK,
Pavone AI, Sawicki J, Fischer SM Progressive Metaplastic and Dysplastic Changes in Mouse Pancreas Induced by Cyclooxygenase-2 Overexpression.
Neoplasia 2008 10 : 782–796.

11. Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Takie R, Ohkohchi N, Hyodo
I, Thomas MB, Krishnamurthy S, Carraway KL , Irimura T MUC4 interacts with
ErbB2 in human gallbladder carcinoma: Potential pathobiological implications Eur J
Cancer 2008 44 :1048-56.

12. Matsuda A, Kuno A, Ishida H, Kawamoto T, Shoda J, Hirabayashi J Development of
an all-in-one technology for glycan profiling targeting formalin- embedded tissue
sections. Biochem Biophys Res Commun. 2008 370:259-63.

13. Kawamoto T, Krishnamurthy S, Tarco E, Trivedi S, Wistuba II, Li D, Roa I, Roa JC, Thomas MB HER receptor family: Novel candidate for targeted therapy for gallbladder and extrahepatic bile duct cancer. Gastrointest Cancer Res 2007 6: 221-227

14. Kiguchi K, Ruffino L, Kawamoto T, Franco E, Kurakata S, Fujiwara K, Hanai M, Rumi M, DiGiovanni J Therapeutic effect of CS-706, a specific cyclooxygenese-2 inhibitor, on gallbladder carcinoma in BK5.ErbB-2 mice. Mol Cancer Ther. 2007 6: 1709-17

15. Wu Q, Kiguchi K, Kawamoto T, Ajiki T, Traag J, Carbajal S, Ruffino L, Thames H,
Wistuba I, Thomas M, Vasquez KM, DiGiovanni J Therapeutic effect of rapamycin
on gallbladder cancer in a transgenic mouse model. Cancer Res. 2007 67: 3794-
3800

16. Kurata M, Okajima K, Kawamoto T, Uchiba M, Ohkohchi N Antithrombin reduces
reperfusion-induced hepatic metastasis of colon cancer cells. World J Gastroenterol.
2006 12: 60-65

17. Kiguchi K, Ruffino L, Kawamoto T, Ajiki T, DiGiovanni J Chemopreventive
and therapeutic efficacy of orally active tyrosine kinase inhibitors in a transgenic
mouse model of gallbladder carcinoma.. Clin Cancer Res. 2005 11: 5572 – 5580

18. Ghosh M, Kamma H, Kawamoto T, Koike N, Miwa M, Kapoor VK, Krishnani N,
Agrawal S, Ohkohchi N, Todoroki T MUC1 core protein as a marker of gallbladder
malignancy. Eur J Surg Oncol 2005 31: 891 – 896

19. Iwai T, Kudo T, Kawamoto R, Kubota T, Togayachi A, Hiruma T, Kawamoto T,
Morozumi K, Narimatsu H Core 3 synthase is down- regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. Proc.Natl. Acad. Sci. USA　2005 102: 4572-4577

20. Ghosh M, Koike N, Tsunoda S, Hirano T, Kaul S, Kashiwagi H, Kawamoto T, Ohkohchi N, Saijo K, Ohno T, Miwa M, Todoroki T
Characterization and genetic analysis in the newly established human bile duct
cancer cell lines. Int J Oncol 2005 26: 449-56

21. Kawamoto T, Shoda J, Miyahara N, Suzuki H, Furukawa M, Todoroki T,
Tanaka N, Irimura T 　Expression of MUC1 recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor aggressiveness of carcinoma of the gallbladder. Clin Exp Metastasis 2004 21: 353-362

22. Suzuki H, Shoda J, Kawamoto T, Shinozaki E, Miyahara N, Hotta S, Iizuka Y, Nakahara A, Tanaka N, Yanaka A, Irimura T Expression of MUC1
recognized by monoclonal antibody MY.1E12 is a useful biomarker for tumor
aggressiveness of advanced colon carcinoma. Clin Exp Metastasis 2004
21: 321-329

23. Miyahara N, Shoda J, Kawamoto T, Furukawa M, Ueda T, Todoroki T, Tanaka N,
Matsuo K, Yamada Y, Kohno K, Irimura T
Expression of UDP-N-acetyl-α-D- galactosamine-polypeptide Gal Nac N-
acetylgalactosaminyl transferase isozyme 3 in the subserosal layer correlates
with postsurgical survival of pathological tumor stage 2 carcinoma of the
gallbladder. Clin.Cancer Res. 2004 10: 2090-2099

24. Nozue M, Oshima Y, Taniguchi H, Kawamoto T, Todoroki T, Fukao K
Progressive sigmoidectomy for cancer during the last 24 years in our
department. Hepatogastroenterology 2004 51: 1337-1340

25. Shinozaki E, Adachi S, Shoda J, Kawamoto T, Suzuki H, Irimura T, Ohkohchi N 　Subcellular localization of MUC1 recognized by a monoclonal antibody MY.1E12 correlates with postsurgical prognosis in differentiated type gastric carcinomas of stage II and III Int J Oncol 2004 25: 1257-1265

26. Ghosh M, Koike N, Yanagimoto G, Tsunoda S, Kaul S, Hirano T, Emura F,
Kashiwagi H, Kawamoto T, Ohkohchi N, Saijou K, Ohno T, Miwa M, Todoroki T Establishment and characterization of unique human gallbladder cancer cell lines.
Int. J. Oncol. 2004 24: 1189-1196

27. Nozue M, Taniguchi H, Kawamoto T, Koike N, Shinozaki E, Adachi S,
　　Todoroki T, Fukao K Refractory proctosigmoiditis probably caused by
　　inferior mesenteric vein ligation at sigmoidectomy. Hepatogastroenterology 　
2004 51: 980-982

28. Todoroki T, Koike N, Morishita Y, Kawamoto T, Ohkohchi N, Shoda J, Fukuda Y, Takahashi H Patterns and predictors of failure after curative resections of carcinoma of the ampulla of Vater. Ann. Surg. Oncol. 2003 10: 1176-1183

29. Nakagawa Y, Todoroki T, Kondo T, Kawamoto T, Ohkohchi N, Ohara K
A salvage treatment for solid liver metastasis after radical resection of Klatskin
tumour. HPB 2003 5: 254-257

30. Shoda J, Suzuki H, Sugiyama Y, Hirouchi M, Utsunomiya H, Oda K, Kawamoto T, Matsuzaki Y, Tanaka N Novel mutations identified in the human multidrug resistance-associated protein 2 (MRP2/ABCC2) gene in a Japanese patient with Dubin-Johnson syndrome. Hepatol. Res. 2003 27: 322-325

31. Shoda J, Ueda T, Kawamoto T, Todoroki T, Asano T, Sugimoto Y, Ichikawa A, Maruyama T, Nimura Y, Tanaka N Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis.
Clin Gastroenterol Hepatol 2003 1: 285-296

32. Liengswangwong U, Nitta T, Kashiwagi H, Kikukawa H, Kawamoto T,
　 Todoroki T, Uchida K, Khuhaprema T, Karalak A, Srivatanakul P, Miwa M 　　　
Infrequent microsatellite in stability in liver fluke infection-associated intrahepatic
cholangiocarcinomas from Thailand. Int. J. Cancer 2003 107: 375-380

33. Emura F, Kamma H, Ghosh M, Koike N, Kawamoto T, Saijou K, Ohno T, Ohkouchi N, Todoroki T Establishment and characterization of novel xenograft models of human biliary tract carcinomas. Int J Oncol 2003 23: 1293-1300

34. Adachi S, Inagawa S, Enomoto T, Shinozaki E, Oda T, Kawamoto T
　 Subjective and functional results after total gastrectomy: prospective study for longterm comparison of reconstruction procedures. Gastric Cancer 2003 6: 24-29

35. Gunji N, Miyamoto H, Orii K, Kawamoto T, Fukao K Pancreatic carcinoid: transcatheter arterial chemoembolization of liver metastasis. 　　　Hepatogastroenterology 2003 50: 2166-2168

36. Enomoto T, Todoroki T, Koike N, Kawamoto T, Matsumoto H 　　　Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer. Hepatogastroenterology 2003 50: 1255-1258

37. Ishiguro S, Takada Y, Gu M, Fukunaga K, Taniguchi H, Seino K, Kawamoto T,
Yuzawa K, Otsuka M, Todoroki T, Fukao K Auxiliary partial orthotopic liver transplantation for fulminanat hepatitis: regeneration of the diseased native liver in a pig model. Transplantation 2003 75: 1901-1904 　
　　
38. Inagawa S, Itabashi M, Adachi S, Kawamoto T, Hori M, Shimazaki J, Yoshimi F, Fukao K 　Expression and prognostic roles of [beta]-catenin in hepatocellular carcinoma: Correlation with tumor progression and postoperative survival.
Clin. Cancer Res. 2002 8 : 450-456

39. Kawamoto T, Shoda J, Asano T, Ueda T, Furukawa M, Koike N, Tanaka N, Todoroki T, Miwa M Expression of cyclooxygenase-2 in the subserosal layer correlates with postsurgical prognosis of pathological tumor stage 2 carcinoma of the gallbladder
Int. J. cancer 2002 98: 427-434

40.Asano T, Shoda J, Ueda T, Kawamoto T, Todoroki T, Shimonishi M, Tanabe T,
Sugimoto Y, Ichikawa A, Mutoh M, Tanaka N, Miwa M 　Expressions of
cyclooxygenase-2 and prostaglandin E-receptors in carcinoma of the gallbladder:
crucial role of arachidonate metabolism in tumor growth and progression.
Clin. Cancer Res. 2002 8: 1157-1167

41. Nozue M, Oshiro Y, Kurata M, Seino K, Koike N, Kawamoto T, Taniguchi H, Todoroki T, Fukao K Treatment and prognosis in colorectal cancer patients with bone metastasis. Oncol. Rep. 2002 9: 109-112

42. Kanazawa N, Oda T, Gunji N, Nozue M, Kawamoto T, Todoroki T, Fukao K
E-cadherin expression in the primary tumors and metastatic lymph nodes of poorly differentiated types of rectal cancer. Surg. Today 2002 32: 123-128

43. Nozue M, Isaka N, Maruyama, Kawamoto T, Seino KI, Taniguchi H, Fukao K Treatment of advanced colorectal adenocarcinoma with weekly high-dose l-leucovorin and 5-fluorouracil Oncol Rep. 2002 9: 93-96

44. Kawamoto T, Shoda J, Irimura T, Miyahara N, Furukawa M, Ueda T, Asano T,
Kano M, Koike N, Fukao K, Tanaka N, Todoroki T
Expression of MUC1 mucins in the subserosal layer correlates with postsurgical
prognosis of pathological tumor stage 2 carcinoma of the gallbladder
Clin. Cancer Res. 2001 7: 1333-1342

45. Inagawa S, Hori M, Shimazaki J, Matsumoto S, Ishii H, Itabashi M, Adachi S,
Kawamoto T, Fukao K Solitary schwannoma of the colon: Report of two cases
Surgery Today　2001 31: 833-838

46. Inagawa S, Shimazaki J, Hori M, Yoshimi F, Adachi S, Kawamoto T, Fukao K,
Itabashi M Hepatoid adenocarcinoma of the stomach.
　Gastric Cancer 2001 4: 43-52

47. Todoroki T, Kawamoto T, Koike N, Fukao K, Shoda J, Takahashi H
Treatment strategy for patients with middle and lower third bile duct cancer　 Br J Surg 2001 88: 364-370

48. Takada Y, Otsuka M, Seino K, Taniguchi H, Koike N, Kawamoto T,
Koda K, Adachi S, Yuzawa, K, Nozue M, Todoroki T, Fukao K
Hepatic resection for metastatic tumors from noncolorectal carcinoma Hepatogastroenterology 2001 48: 83-86

49. Oshima Y, Nozue M, Taniguchi H, Seino KI, Koike N, Kawamoto T, Todoroki T, Fukao K Transition and improvement in surgical treatment for rectal cancer during the last 21 years in our department. 　　　 Int. J. Oncol. 2001 19: 1283-1286

50. Ghosh M, Kawamoto T, Koike N, Fukao K, Yoshida S, Kashiwagi H, Kapoor VK, Agarwal S, Krishnani N, Uchida K, Miwa M, Todoroki T Cyclooxygenase expression in the gallbladder
Int J Mol Med 2000 6 : 527-532

51. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M , Fukao K Radical resection of hilar bile duct carcinoma and predictors of survival　Br J Surg 2000 87: 306-313

52. Adachi S, Kawamoto T, Otsuka M, Todoroki T , Fukao K
Enteral vitamin B12 supplements reverse postgastrectomy B12 deficiency Ann Surgery 2000 232 : 199-201

53. Koike N, Todoroki T, Kawamoto T, Inagawa S, Yoshida S, Fukao K
Amputation neurinoma mimics common hepatic duct carcinoma Heptogatroenterology 2000 47 : 639-643

54. Inagawa S, Adachi S, Oda T, Kawamoto T, Koike N, Fukao K
Effect of fat volume on postoperative complications and survival rate after D2 dissection for gastric cancer Gastric Cancer 2000 3 : 141-144

55. Todoroki T, Kawamoto T, Koike N, Takahashi H, Yoshida S, Kashiwagi H, Takada Y, Otsuka M, Fukao K Radical resection of hilar bile duct carcinoma and predictors of survival Br J Surg 2000 87: 306-313

56. Todoroki T , Ohara K, Kawamoto T, Koike N , Yoshida S, Kashiwagi H, Otsuka M, Fukao K Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma. Int J Radiat Oncol Biol Phys 2000 46: 581-587

57. Todoroki T, Kawamoto T, Takahashi H, Takada Y, Koike N, Otsuka M, Fukao K Treatment of gallbladder cancer by radical resection Br J Surg 199986: 622-627

58. Todoroki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y, Adachi S , Kashiwagi H, Fukao K, Ohara K
Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer Hepatogastroenterology 1999 46: 1585-1591

59. Todoroki T, Takahashi H, Koike N, Kawamoto T, Kondo T, Yoshida S, Kashiwagi H, Otsuka M, Fukao K, Saida Y Outcome of aggressive treatment of stage IV gallbladder cancer and predictors of survival Hepatogastroenterology 1999 46: 2114-2121

60. Fukunaga K, Todoroki T, Takada Y, Otsuka M, Kawamoto T, Fukao K
Hepatic functional reserve in patients with biliary malignancies; an assessment by technetium 99m galacosyl human serum albumin hepatic scintigraphy Int Surg 1999 84: 199-203

61. Gunji N, Oda T, Todoroki T, Kanazawa N, Kawamoto T, Yuzawa K, Scarpa A,
Fukao K Pancreatic carcinoma correlation between E-cadherin and α-catenin
expression status and liver metastasisCancer 1998 82: 1649-1656　

62. Koike N, Todoroki T, Kawamoto T, Yoshida S, Kashiwagi H, Fukao K, Ohno T, Watanabe T The invasion potentials of human biliary tract carcinoma cell lines :
correlation between invasiveness and morphologic characteristics
Int J Oncol 1998 13:1269-1274

63. Koike N, Saitoh K, Todoroki T, Kawamoto T, Iwasaki Y, Nakamura K
Cell proliferation kinetics of the bile duct epithelium of the rat.
Cell Prolif. 1993 26: 183-193

64. Todoroki T, Fukuda Y, Kawamoto T, Saida Y, Ohara K, Iwasaki Y, Matsuzaki O Long-term survivors after salvage surgery combined with radiotherapy for recurrence of stage IV main hepatic duct cancer – Report of two cases Hepatogastroenterology Current medical and Surgical Trends 1993 3: 285-293

65. Nozue M, Koike N, Kawamoto T, Toko, K ,Sindou T, Orii K, Kondou T, Mun Y, Nitou M, Todoroki T, Dependence of the thymidylate synthase inhibition rate on the interval after the last administration of tegafur in sigmoid colon cancer patients.
J Surg Oncol 1993 52: 115-118

66. Todoroki T, Iwasaki Y, Orii K, Otsuka M, Ohara K, Kawamoto T, Nakamura K
Resection combined with itraoperative radiation therapy (IORT) for stage IV(TNM) gallbladder carcinoma World J Surg 1991 15: 357-366
＃２
海外招聘講演
3rd International Postgraduate Course
Hepato Pancreatico Biliary Disease To-day KKU-IGSC Joint Project 2000 Jan
“Immuno Histochemical Expression of Cyclooxygenase in Diseased Biliary Tract”
2006 ASCO Annual Meeting（Atlanta）

Plenary session
GASTROINTESTINAL (NONCOLORECTAL) CANCER
Amplification of HER-2/neu (erbB2) gene expression in gallbladder (GBC) and in bile duct cancer (BDC) (biliary tract cancer, BTC)
T. Kawamoto , M. Thomas , E. Tarco , S. Trivedi , I. Wistuba , S. Krishnamurthy

（日本原作者）
1. HER family：肝内胆管癌的潜在药物靶点 川本徹、山本雅一、正田純一
肝胆胰 第72卷　第1期 107-114　2016
2. COX-2-HER family 通路角度观察寄生虫相关肝内胆管癌
川本徹, 山本雅一 胆和胰 第34卷　第6期 475-479 2013
3.糖基转移酶 N-acetyl glucosamine V (GnT-V) 在肝内胆管癌中的表达及其临床病理意义 小貫建一郎、正田純一、川本徹、有泉俊一、山本雅一　东京女子医科大学杂志 第82卷 第２期 62-69, 2012
4.使用 ErbB2 转基因小鼠开发胆囊癌分子靶向治疗*
川本徹　胆和胰 第31卷　第4期　395-408, 2010
5.慢性胆道疾病的癌变、胆道癌发生过程的分子机制
川本徹, 正田純一　肝胆胰 第58卷　第6期 731-740 2009
6. 正田純一、石毛和紀、杉山弘明、川本　徹 胆道癌的分子靶向治疗关于《可能性》　胆道　第 3 卷　第 5 期 762-774 2009
7. 川本　徹、谷畑英一、玄　東吉、湊　志仁、服部光治、下條ゑみ、椎貝達夫
接受体检和一般健康检查者血清幽门螺杆菌 IgG 抗抗生素论身体测量的意义和有用性，《日本农业医学杂志》，第 58 卷　第 4 期，452-458　2009
8. 川本　徹、正田純一　 慢性胆道疾病的癌变机制及胆道癌进展过程中的分子机制 肝胆胰　第 58 卷　第 6 期 731-740 2009
9. 松尾亮太、近藤　匡、川本　徹、文　由美、山本祐二、竹島　徹、轟　健、大河内信弘 长期化疗存活的肝门部胆管癌术后腹膜播散病例. 癌症与化疗　第34卷　第 10期　1675-1678　2007
10. 川本　徹、Ruffino Lynnsie、味木徹夫、DiGiovanni John、木口　薫
ErbB2 蛋白在胆囊癌发生中的表达 – 使用 ErbB2 转基因小鼠胆囊癌进行研究 – 胆道 第 19 卷　第 5 期　550-556 2005
11. 篠崎英司、太田恵一朗、福永　潔、山本雅由、寺島秀夫、小池直人、小田竜也、川本　徹、湯沢賢治 我科上段胃癌切除病例的临床病理学研究. 日本胃肠病学会杂志， 第37卷　第10期　1692-1693 2004
12. 中川裕司、轟　健、小池直人、川本　徹　 一例原发部位不明的腺癌，肿瘤切除术后辅助化疗后长期未复发 癌症与化疗 第30卷 第3期 423-426 2003
13. 轟　健、湯沢賢治、川本　徹、高田泰次 胆囊癌切除与血运重建手术　　
第 57 卷　第 2 期 151-156 2003
14. 川本　徹、篠崎英司、高田泰次、湯沢賢治、足立信也、小田竜也、　　　寺島秀夫、轟　健、大河内信弘 肝胆癌术后感染深部真菌病的实际情况及其对策 – 肝切除术后急性肝功能衰竭病例的真菌病检查 – 日本急诊医学杂志，第 24 卷　第1期　49-56 2003
15. 中川裕司、轟　健、小池直人、川本　徹　一例原发部位不明的腺癌，肿瘤切除术后辅助化疗后长期无复发一例《癌症与化疗》第30卷　第3期　423-426　2003
16. 轟　健、川本　徹、安部井誠人 上、中胆管癌的胆管切除和重建手术　　第 56 卷　第 9 期 1291-1296 2002
17. 川本　徹、正田純一、田中直見 胆石症胆囊炎和螺杆菌属 (spp.)
肝胆胰　第 45 卷　第 1 期 15-19 2002
18. 吉田貞夫、近藤　匡、轟　健、小池直人、川本　徹、中川裕司、深尾　立、清水わか子、大原　潔、文　由美、山本佑二 通过放射、化疗和切除相结合提高晚期食管癌的治疗效果 一个例子：癌症与化疗　第 28 卷第 8 期 1145-1148 2001
19. 川本　徹　、正田純一、小池直人、浅野　徹、轟　健、深尾　立
从唾液酸化MUC1表达角度观察SS胆囊癌的临床病理学
千年胃肠病学 2000（肝脏、胆汁、胰腺）（无裁判） 日本胃肠病学会 291-294 2000
20. 倉田昌直、高田泰次、川本　徹、等 MTX5FU 替代疗法对乙状结肠切除术后骨髓癌引起的 DIC 有效的病例 日本临床外科学会杂志 第 41 卷　299-300 2000
21. 足立信也、川本　徹、高田泰次、小池直人、榎本剛史、篠崎英司、
轟　健、深尾　立　全胃切除术后的生活质量——重建技术和口服维生素——
日本外科学会杂志　第 25 卷　第 6 期 821-825 2000
22. 大島裕二、谷口英樹、高田泰次、大塚雅昭、湯沢賢治、中橋ちぐさ、
榎本剛史、石黒慎吾、金沢伸郎、稲川　智、足立信也、幸田圭史、川本　徹、小田竜也、小池直人、轟　健、深尾　立　肾移植后卡氏肺炎一例因早期诊断可治愈，无需严重病程移植　第35卷　第1期　13-18　2000
23. 吉田貞夫、轟　健、小池直人、川本　徹　、深尾　立、清水わか子、大原　潔、近藤　匡　、文　由美、山本祐二　晚期食管癌的放化疗　第13届兼越UFT研究小组（2000年）讲座集第2期（无裁判）21-24　2000
24. 野末 睦, 工藤 寿美, 井坂 直秀, 丸山 常彦, 金沢 伸郎, 小田 竜也, 福永 潔, 川本 徹, 小池 直人, 石黒 慎吾, 足立 信也, 高田 泰次, 湯沢 賢治, 大塚 雅昭, 轟 健, 深尾 立　癌症申报偏好调查前后申报状况的变化——以治疗组各成员的变化为中心 日本外科学会杂志　第24 卷　第１期　58-63 1999
25. 小池直人、轟　健、川本　徹、大塚雅昭、高田泰次、吉田貞夫、
幸田圭史、谷口英樹、足立信也、深尾　立　十二指肠乳头状癌治疗结果与预后因素的关系　筑波研讨会（无裁判）第 15 卷 61-67 1999
26. 吉田貞夫、轟　健、小池直人、丸山常彦、川本　徹、深尾　立、清水わか子、大原　潔、物井　久、山本裕二、河合勇一　 放化疗成功的晚期食管癌三例　癌症与化疗　第 26 卷　第 9 期 1343-1347 1999
27. 丸山常彦、轟　健、川本　徹、足立信也、武内俊章、吉田貞夫、小池直人、大塚雅昭、深尾　立、清水わか子、大原　潔、河合勇一、山本裕二、
物井　久 胆管镜引导下微波凝固在下段胆管癌治疗中的应用
胆道　第 12 卷　第 3 期 270-275 1998
28. 大塚雅昭、高田泰次、谷口英樹、小池直人、足立信也、小田竜也、
川本　徹、金沢伸郎、稲川　智、石黒慎吾、福永　潔、轟　健、深尾　立、小林達司、長田道夫、小山　哲夫、赤座英之　尸体肾移植案例中，患者因自体肾（囊性肾）感染恶化而疑似死亡　今日移植 第 11 卷　第 6 期 883-884 1998
29. 井坂直秀、野末　睦、足立信也、小池直人、川本　徹、深尾　立　甲氨蝶呤5FU、5FU甲酰四氢叶酸交替治疗成功治疗低分化直肠癌一例
日本结肠直肠学会杂志　第51卷　第7期　479-484 1998
30. 川本　徹、轟　健、小池直人、金沢伸郎、深尾　立、斉藤　澄、　　　　　中村恭一　肝门部胆管癌肝胆管进展模式的检查
胆道　第 10 卷　第 2 期 131-137 1996
31. 轟　健、川本　徹、吉田貞夫、文　由美、小池直人、福永　潔、
近藤　匡、深尾　立　肝门部胆管癌的病理情况及治疗结果
日本医学博物馆胃肠癌（无裁判）第6卷　第6期　551-558 1996
32. 轟　健、吉田貞夫、川本　徹、近藤　匡、小池直人、金澤伸郎、
野末　睦、足立信也、深尾　立、福田禎治、飯田浩行、小野　陸、仁藤　学　“CDDP静脉注射+UFT口服”在IV期（pTNM）胆道癌术后化疗中的药代动力学及小剂量给药效果　癌症与化疗　第九回兼越 UFT研究小组第8场（无裁判）87-93 1996
33. 轟　健、川本　徹 胆囊燕麦细胞癌 区域综合征系列 第 9 卷　251-255 1996
34. 福田禎治、轟　健、川本　徹、小池直人、菊池正教、菅原陽一、深尾　立　 十二指肠乳头状癌切除病例的预后因素分析
胆道　第 9 卷　第 3 期 241-252 1995
35. 文　由美、轟　健、川本　徹、吉田貞夫、小池直人、福永　潔、近藤　　　匡、物井　久、湯沢賢治、大塚雅昭、深尾　立　 粘膜内胆道门部胆管癌切除病例 日本临床外科医师学会杂志　第56 卷　第 12 期 2695-2699 1995
36. 轟　健、 川本　徹、野末　睦、小池直人、加藤修志、折居和雄
肝门部胆管癌预后因素的检查 – 10例生存5年以上与58例生存不足5年的比较 – 日本胃肠病学会外科学会杂志 第 26 卷　第4 期1130-1136 1993
37. 福永　潔、野末　睦、文　由美、物井　久、山本佑二、長田　明、
川本　徹、小池直人、深尾　立　 肝吸虫合并肝门部胆管癌一例　日本疾病学会杂志　第 90 卷第 5 期　1467-1471 1993
38. 川本　徹、斉藤　澄、轟　健、小池直人、金澤伸郎、岩崎洋治、　　　　中村恭一　使用抗增殖细胞核抗原（PCNA）抗体研究胆门胆管癌的细胞增殖能力。PCNA表达与CEA、CA19-9和EGF受体表达的关系。日本胃肠病学会杂志，第90卷，第2期. 144 -153 1993
39. 轟　健、川本　徹、小池直人 胆道癌 – 切除病例的治疗 放射治疗 术中照射 国际医学出版《肝胆胰》第 25 卷　第 4 期 763-773 1992
40. 轟　健、 川本　徹、上半部分：胆门胆管癌的放射治疗：旨在提高治愈率和高生活质量标准 日本医学会胃肠癌 第 2 卷　第 2 期 156-167 1992
41. 轟　健、仁藤　学、小池直人、深尾　立、川本　徹 胰体尾癌 – 胰腺癌治疗方法的选择 医学书院临床外科
第 47 卷　第 8 期 1023-1039 1992
42. 轟　健、川本　徹、小池直人、折居和雄、大塚雅昭、上田　廣、
河合勇一、岡村隆夫、岩崎洋治　肝门部胆管癌术后长期生存病例的临床病理学研究　日本消化器外科学会杂志　第24卷　第6期1341-1350 1991